JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23B |
| 2 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$438M |
| 3 |
Royal Caribbean
RCL
|
+$434M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$432M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$424M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.08B |
| 2 |
Meta Platforms (Facebook)
META
|
+$722M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$721M |
| 4 |
Apple
AAPL
|
+$701M |
| 5 |
Netflix
NFLX
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.51% |
| 2 | Financials | 13.49% |
| 3 | Technology | 11.69% |
| 4 | Healthcare | 10.22% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
VRN
2476
DELISTED
Veren
VRN
| $2.38M | ﹤0.01% |
171,854
+32,496
| +23% | +$376K |
2014 Q1
8 quarters
|
|
|
SUNS
2477
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
| $2.38M | ﹤0.01% |
162,979
+9,768
| +6% | +$136K |
2013 Q2
11 quarters
|
|
2478
Southside Bancshares
SBSI
$900M
| $2.37M | ﹤0.01% |
97,743
+4,611
| +5% | +$100K |
2014 Q4
5 quarters
|
|
2479
CALL
Gold Fields
GFI
$32.2B
| $2.36M | ﹤0.01% |
+600,000
| New | +$2.24M |
2016 Q1
0 quarters
|
|
|
CBPO
2480
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $2.36M | ﹤0.01% |
+20,644
| New | +$2.42M |
2016 Q1
0 quarters
|
|
2481
National Presto Industries
NPK
$1.06B
| $2.36M | ﹤0.01% |
28,180
-8,870
| -24% | -$710K |
2015 Q2
3 quarters
|
|
2482
Geospace Technologies
GEOS
$60.7M
| $2.36M | ﹤0.01% |
190,913
-5,887
| -3% | -$64.9K |
2015 Q3
2 quarters
|
|
|
REXX
2483
DELISTED
Rex Energy Corporation
REXX
| $2.36M | ﹤0.01% |
306,708
-80,287
| -21% | -$711K |
2014 Q4
5 quarters
|
|
|
EFOR
2484
Everforth Inc
EFOR
$1.47B
| $2.35M | ﹤0.01% |
63,699
-3,286
| -5% | -$116K |
2013 Q2
11 quarters
|
|
|
HEES
2485
DELISTED
H&E Equipment Services
HEES
| $2.33M | ﹤0.01% |
133,129
+131,723
| +9,369% | +$1.91M |
2015 Q4
1 quarter
|
|
|
SAVE
2486
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
| $2.33M | ﹤0.01% |
+48,600
| New | +$2.17M |
2016 Q1
0 quarters
|
|
2487
Axalta
AXTA
$7.15B
| $2.33M | ﹤0.01% |
79,815
-208,934
| -72% | -$5.31M |
2015 Q3
2 quarters
|
|
|
FOLD
2488
PUT
DELISTED
Amicus Therapeutics
FOLD
| $2.32M | ﹤0.01% |
+274,200
| New | +$1.94M |
2016 Q1
0 quarters
|
|
2489
CALL
Vale
VALE
$59.9B
| $2.32M | ﹤0.01% |
550,000
-330,900
| -38% | -$1.03M |
2014 Q4
5 quarters
|
|
2490
Acacia Research
ACTG
$426M
| $2.31M | ﹤0.01% |
610,960
+610,698
| +233,091% | +$2.24M |
2015 Q4
1 quarter
|
|
|
IPXL
2491
DELISTED
Impax Laboratories, Inc.
IPXL
| $2.31M | ﹤0.01% |
72,197
-19,399
| -21% | -$682K |
2013 Q2
11 quarters
|
|
2492
Ooma
OOMA
$548M
| $2.3M | ﹤0.01% |
390,280
-306,920
| -44% | -$1.96M |
2015 Q3
2 quarters
|
|
|
BSMX
2493
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $2.3M | ﹤0.01% |
+254,420
| New | +$2.03M |
2016 Q1
0 quarters
|
|
2494
AngloGold Ashanti
AU
$47.3B
| $2.3M | ﹤0.01% |
167,735
-442,561
| -73% | -$4.8M |
2014 Q2
7 quarters
|
|
|
WFT
2495
CALL
DELISTED
Weatherford International plc
WFT
| $2.29M | ﹤0.01% |
294,477
+142,977
| +94% | +$965K |
2014 Q3
6 quarters
|
|
|
AGTC
2496
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.29M | ﹤0.01% |
163,589
-10,923
| -6% | -$160K |
2014 Q2
7 quarters
|
|
|
LNKD
2497
CALL
DELISTED
LinkedIn Corporation
LNKD
| $2.29M | ﹤0.01% |
20,000
+18,400
| +1,150% | +$2.7M |
2014 Q3
6 quarters
|
|
2498
Lakeland Financial Corp
LKFN
$1.44B
| $2.29M | ﹤0.01% |
74,888
-1,077
| -1% | -$31.2K |
2013 Q2
11 quarters
|
|
2499
Harmonic Inc
HLIT
$1.22B
| $2.28M | ﹤0.01% |
697,561
+104,400
| +18% | +$342K |
2013 Q2
11 quarters
|
|
|
SRG
2500
Seritage Growth Properties
SRG
$96.9M
| $2.28M | ﹤0.01% |
+45,613
| New | +$1.89M |
2016 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2016 Portfolio in Review
As of Q1 2016, JP Morgan Chase held 5,307 positions worth $391B, down 1.9% from $398B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2016 filing shows 536 new, 1,742 increased, 1,913 reduced and 585 closed positions. Its largest new stake was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $1.08B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 20% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2016 buy was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q1 2016, an estimated $2.23B increase.
- JP Morgan Chase's biggest Q1 2016 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $1.08B.
- JP Morgan Chase fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $721M.
- JP Morgan Chase's ten largest holdings make up 17% of its $391B portfolio in Q1 2016.
- JP Morgan Chase opened 536 new positions and closed 585 in Q1 2016.
- JP Morgan Chase's portfolio value fell 1.9% quarter-over-quarter to $391B.
Based on JP Morgan Chase's 13F filing for Q1 2016, filed 10 May 2016.